This inventor holds 1 USPTO granted patent. Top assignee: Baylor College of Medicine. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Antonio Pizzuti: Innovator in Myotonic Muscular Dystrophy Diagnosis
Introduction
Antonio Pizzuti is a notable inventor based in Milan, Italy. He has made significant contributions to the field of genetics, particularly in the diagnosis of myotonic muscular dystrophy. His work has implications for understanding and detecting this genetic disorder, which affects muscle function.
Latest Patents
Antonio Pizzuti holds a patent for the "Diagnosis of myotonic muscular dystrophy." This invention includes a DNA clone from the myotonic muscular dystrophy gene and a cosmid probe to the myotonic dystrophy site. The methods described in the patent involve detecting myotonic muscular dystrophy using restriction fragment length polymorphism (RFLP). The process includes digesting DNA from an individual with a restriction endonuclease and detecting the resulting fragments through hybridization and southern blot analysis. Additionally, the gene can be measured by assessing mRNA levels or protein amounts using antibodies. The patent also outlines methods for detecting the gene defect using fluorescence in situ hybridization or pulsed field gel electrophoresis.
Career Highlights
Antonio Pizzuti is affiliated with Baylor College of Medicine, where he continues to advance research in genetic disorders. His work has been instrumental in developing diagnostic techniques that can lead to better patient outcomes.
Collaborations
Some of his notable coworkers include C Thomas Caskey and Ying-Hui Fu. Their collaborative efforts contribute to the ongoing research and development in the field of genetics.
Conclusion
Antonio Pizzuti's innovative work in the diagnosis of myotonic muscular dystrophy showcases the importance of genetic research in medicine. His contributions are vital for improving diagnostic methods and understanding genetic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
